The RSV-NICA model is a modern, GMP-manufactured RSV-A controlled human infection model (CHIM), developed and owned by SGS in Belgium. It supports rapid proof-of-concept for RSV vaccines and antivirals in a fully integrated European setting.
What you'll find in this technical sheet:
- A clear overview of the RSV-NICA strain origin and GMP manufacturing
- Clinical validation data of a proof-of-concept study, showing 100% attack rate
- How the integrated Belgian CHIM set-up accelerates RSV development
Loading...